Does TOCILIZUMAB Cause Haematocrit decreased? 143 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 143 reports of Haematocrit decreased have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.2% of all adverse event reports for TOCILIZUMAB.
143
Reports of Haematocrit decreased with TOCILIZUMAB
0.2%
of all TOCILIZUMAB reports
3
Deaths
92
Hospitalizations
How Dangerous Is Haematocrit decreased From TOCILIZUMAB?
Of the 143 reports, 3 (2.1%) resulted in death, 92 (64.3%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Haematocrit decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 143 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Haematocrit decreased?
CLOZAPINE (1,027)
RUXOLITINIB (562)
ECULIZUMAB (466)
ADALIMUMAB (455)
NIRAPARIB (406)
METHOTREXATE (396)
PALBOCICLIB (357)
RITUXIMAB (328)
ALEMTUZUMAB (283)
PREDNISONE (283)
Which TOCILIZUMAB Alternatives Have Lower Haematocrit decreased Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE